2006
DOI: 10.1089/hyb.2006.25.300
|View full text |Cite
|
Sign up to set email alerts
|

Monoclonal Antibodies to Mechano-Growth Factor

Abstract: Two hybridoma clones secreting monoclonal antibodies (MAbs) to mechano-growth factor (MGF) have been produced by cell fusion technique. Isotyping of the MAbs revealed that both belong to the G1 subclass. The epitope specificity of the MAbs has been examined in competition experiments. No competition was detected, suggesting that the MAbs obtained recognize different antigenic determinants. MAbs of one clone (8B9) recognize human MGF peptide absent in insulin-like growth factor-1 (IGF-1) and comprising amino ac… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
8
0

Year Published

2008
2008
2019
2019

Publication Types

Select...
9

Relationship

2
7

Authors

Journals

citations
Cited by 16 publications
(9 citation statements)
references
References 24 publications
1
8
0
Order By: Relevance
“…A synthetic peptide corresponding to the 24 C-terminal amino acids of the Eb E peptide stimulated proliferation and inhibited differentiation of C2C12 cells (Yang and Goldspink, 2002). Because antibodies raised against this sequence have detected proteins larger than the intact Eb peptide or the 24-aa C-terminal fragment (Dluzniewska et al, 2005; Kravchenko et al, 2006; Philippou et al, 2008) and no published reports exist where this IGF-I Eb mRNA product has been identified in, or isolated from, injured tissues in vivo , the identity of the precise form or physiological role of MGF remains elusive.…”
Section: Discussionmentioning
confidence: 99%
“…A synthetic peptide corresponding to the 24 C-terminal amino acids of the Eb E peptide stimulated proliferation and inhibited differentiation of C2C12 cells (Yang and Goldspink, 2002). Because antibodies raised against this sequence have detected proteins larger than the intact Eb peptide or the 24-aa C-terminal fragment (Dluzniewska et al, 2005; Kravchenko et al, 2006; Philippou et al, 2008) and no published reports exist where this IGF-I Eb mRNA product has been identified in, or isolated from, injured tissues in vivo , the identity of the precise form or physiological role of MGF remains elusive.…”
Section: Discussionmentioning
confidence: 99%
“…In general, the complexity introduced by the transcriptional and splicing variants, posttranscriptional regulation and posttranslational modifications of the IGF1 gene (77), giving rise to various IGF-I isoforms, probably indicate their different biological roles under various conditions or pathologies and following different stimuli (78). The development of epitope-specific antibodies for distinguishing the different IGF-I E-peptides (20,38,(79)(80)(81)(82) can contribute to a more definitive analysis of IGF-I isoforms expression in various tissues and physiological or pathophysiological conditions.…”
Section: Human Igf1 Gene Structure and Alternative Splicingmentioning
confidence: 99%
“…The cells on a 60 mm Petri dish were lysed by pipetting in 0.2 ml PBS containing 0.05% Tween 20 (PBS-T) and a mixture of protease inhibitors (Sigma-Aldrich, USA). The MGF concentration was measured with a sandwich ELISA assay based on monoclonal antibodies as described earlier [21] using an amplification system. Microtiter plates (Corning-Costar, USA) were coated with 8B9 monoclonal antibody solution (10 μg/ml) overnight at 4 °C.…”
Section: Methodsmentioning
confidence: 99%